{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT02565459",
      "OrgStudyIdInfo": {
        "OrgStudyId": "Third-party MSC-Tx tolerance A"
      },
      "SecondaryIdInfoList": {
        "SecondaryIdInfo": [
          {
            "SecondaryId": "2015-002186-27",
            "SecondaryIdType": "EudraCT Number"
          }
        ]
      },
      "Organization": {
        "OrgFullName": "A.O. Ospedale Papa Giovanni XXIII",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "MSC and Kidney Transplant Tolerance (Phase A)",
      "OfficialTitle": "Third-party Bone Marrow-derived Mesenchymal Stromal Cells to Induce Tolerance in Recipients of Kidney Transplants From Deceased Donors (Phase A)"
    },
    "StatusModule": {
      "StatusVerifiedDate": "April 2018",
      "OverallStatus": "Unknown status",
      "LastKnownStatus": "Recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "September 2015"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "September 2021",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "December 2021",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "September 24, 2015",
      "StudyFirstSubmitQCDate": "September 30, 2015",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "October 1, 2015",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "April 5, 2018",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "April 6, 2018",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor-Investigator",
        "ResponsiblePartyInvestigatorFullName": "Monia Lorini",
        "ResponsiblePartyInvestigatorTitle": "EC Secretary",
        "ResponsiblePartyInvestigatorAffiliation": "A.O. Ospedale Papa Giovanni XXIII"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Monia Lorini",
        "LeadSponsorClass": "OTHER"
      },
      "CollaboratorList": {
        "Collaborator": [
          {
            "CollaboratorName": "Mario Negri Institute for Pharmacological Research",
            "CollaboratorClass": "OTHER"
          }
        ]
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "The general aim of the present study is to test a cell therapy with third-party ex-vivo expanded bone marrow-derived mesenchymal stromal cells (MSCs) as a strategy to induce tolerance in kidney transplant recipients with a deceased donor. MSCs will be prepared accordingly to established protocols, starting from the remnants in the bag and filter at the end of the bone marrow infusions. From these samples, MSCs will be expanded in good manufacturing practice (GMP) approved facilities and used for the present study in patients undergoing kidney transplantation.\n\nThe proposed study will be developed in two phases: i) a pilot explorative safety/biologic-mechanistic phase (Phase A), ii) a pilot efficacy phase (Phase B)."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Chronic Renal Failure"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Mesenchymal stromal cells",
          "kidney transplantation",
          "tolerance"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "22",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Mesenchymal Stromal Cells (MSC)",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "A single intravenous infusion (1-2 millions of MSCs per kilogram body weight) of ex-vivo expanded third-party (from healthy donors) MSCs will be performed in patients randomized to the MSC procedure in addition to the kidney transplantation.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Mesenchymal Stromal Cells"
              ]
            }
          },
          {
            "ArmGroupLabel": "No intervention",
            "ArmGroupType": "No Intervention"
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "Mesenchymal Stromal Cells",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Mesenchymal Stromal Cells (MSC)"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Number of adverse events",
            "PrimaryOutcomeDescription": "At each visit overall clinical condition of the patient will be evaluated and any adverse event will be recorded.",
            "PrimaryOutcomeTimeFrame": "Changes from baseline through study completion, up to 12 months after transplant."
          },
          {
            "PrimaryOutcomeMeasure": "Circulating naive and memory T cell count (CD45RA/CD45RO) (flow cytometry analysis)",
            "PrimaryOutcomeTimeFrame": "Changes from baseline at 7, 14, 30 days after transplant and then every six months through study completion, up to 12 months after transplant."
          },
          {
            "PrimaryOutcomeMeasure": "Circulating regulatory T cell count.",
            "PrimaryOutcomeTimeFrame": "Changes from baseline at 7, 14, 30 days after transplant and then every six months through study completion, up to 12 months after transplant."
          },
          {
            "PrimaryOutcomeMeasure": "T-cell function in mixed lymphocyte reaction.",
            "PrimaryOutcomeDescription": "IFNg-producing T cells (spots/300.000 cells) and CD8+ T cell-mediated cytotoxicity (percentage of specific lysis) will be measured in mixed lymphocyte reaction.",
            "PrimaryOutcomeTimeFrame": "Changes from baseline at 6 and 12 months after transplant."
          },
          {
            "PrimaryOutcomeMeasure": "Urinary FOXP3 mRNA expression evaluated by real time quantitative PCR",
            "PrimaryOutcomeTimeFrame": "Changes from baseline at 6 and 12 months after transplant."
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nFirst single kidney transplant;\nCapable of understanding the purpose and risk of the study;\nWritten informed consent.\n\nExclusion Criteria:\n\nPRA >10%;\nSpecific contraindication to MSC infusion;\nAny clinical relevant condition that might affect study participation and/or study results;\nChildbearing potential without effective contraception;\nPregnant women and nursing mothers;\nUnwillingness or inability to follow study protocol in the investigator's opinion.",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "MaximumAge": "75 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "Norberto Perico, MD",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "0039 035 45351",
            "CentralContactEMail": "norberto.perico@marionegri.it"
          }
        ]
      },
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Giuseppe Remuzzi, MD",
            "OverallOfficialAffiliation": "A.O. Ospedale Papa Giovanni XXIII",
            "OverallOfficialRole": "Study Chair"
          },
          {
            "OverallOfficialName": "Norberto Perico, MD",
            "OverallOfficialAffiliation": "Istituto Di Ricerche Farmacologiche Mario Negri",
            "OverallOfficialRole": "Study Director"
          },
          {
            "OverallOfficialName": "Giovanni Rota, MD",
            "OverallOfficialAffiliation": "A.O. Ospedale Papa Giovanni XXIII",
            "OverallOfficialRole": "Principal Investigator"
          },
          {
            "OverallOfficialName": "Federica Casiraghi",
            "OverallOfficialAffiliation": "Istituto Di Ricerche Farmacologiche Mario Negri",
            "OverallOfficialRole": "Principal Investigator"
          },
          {
            "OverallOfficialName": "Martino Introna, MD",
            "OverallOfficialAffiliation": "Laboratorio G. Lanzani, Bergamo, Italy",
            "OverallOfficialRole": "Principal Investigator"
          },
          {
            "OverallOfficialName": "Alessandro Rambaldi, MD",
            "OverallOfficialAffiliation": "A.O. Ospedale Papa Giovanni XXIII",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "U.O. Nefrologia e Dialisi",
            "LocationStatus": "Recruiting",
            "LocationCity": "Bergamo",
            "LocationZip": "24127",
            "LocationCountry": "Italy",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Piero Ruggenenti, MD",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "0039 035 2674037",
                  "LocationContactEMail": "pruggenenti@hpg23.it"
                },
                {
                  "LocationContactName": "Eliana Gotti, MD",
                  "LocationContactRole": "Sub-Investigator"
                }
              ]
            }
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000007676",
            "ConditionMeshTerm": "Kidney Failure, Chronic"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000051437",
            "ConditionAncestorTerm": "Renal Insufficiency"
          },
          {
            "ConditionAncestorId": "D000007674",
            "ConditionAncestorTerm": "Kidney Diseases"
          },
          {
            "ConditionAncestorId": "D000014570",
            "ConditionAncestorTerm": "Urologic Diseases"
          },
          {
            "ConditionAncestorId": "D000051436",
            "ConditionAncestorTerm": "Renal Insufficiency, Chronic"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M25871",
            "ConditionBrowseLeafName": "Renal Insufficiency",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M5997",
            "ConditionBrowseLeafName": "Death",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M9851",
            "ConditionBrowseLeafName": "Kidney Failure, Chronic",
            "ConditionBrowseLeafAsFound": "Chronic Renal Failure",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M9850",
            "ConditionBrowseLeafName": "Kidney Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M16471",
            "ConditionBrowseLeafName": "Urologic Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M25870",
            "ConditionBrowseLeafName": "Renal Insufficiency, Chronic",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BXS",
            "ConditionBrowseBranchName": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          }
        ]
      }
    }
  }
}